HIGHLIGHTS
- who: Lisa Allander and collaborators from the Department of Medical Sciences, Uppsala University, , Uppsala, Sweden have published the paper: Evaluation of In Vitro Activity of Double-Carbapenem Combinations against KPC-2-, OXA-48- and NDM-Producing Escherichia coli and Klebsiella pneumoniae, in the Journal: Antibiotics 2022, 1646 of /2022/
- what: This study evaluated the activity of doublecarbapenem 51 clinical KPC-2- OXA-48- NDM-1 and and and constructed E. strains harboring genes encoding KPC-2 OXA-48 or NDM-1 in an otherwise isogenic background. The authors evaluated the activity of two-drug combinations . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.